Antonio Furlan

Safety and efficacy of an oral histone deacetylase inhibitor in systemic‐onset juvenile idiopathic arthritis

Jelena Vojinović, Nemanja Damjanov, Carmine D’Urzo et al. · Arthritis & Rheumatism · 2011 · 214 citations

Pharmacokinetics, Safety and Inducible Cytokine Responses during a Phase 1 Trial of the Oral Histone Deacetylase Inhibitor ITF2357 (Givinostat)

Antonio Furlan, V. Monzani, Leonid L. Reznikov et al. · Molecular Medicine · 2011 · 116 citations · Full text

The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro

Shay Matalon, Brent E. Palmer, Marcel F. Nold et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 82 citations · Full text

Elderly onset of primary Sjögren's syndrome: Clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients

Costantino Botsios, Antonio Furlan, Pierantonio Ostuni et al. · Joint Bone Spine · 2010 · 65 citations

Rheumatology, Autoimmune Disease, Ophthalmology +7

Optic neuropathy: a rare paraneoplastic syndrome.

Sonika Malik, Antonio Furlan, Patrick J. Sweeney et al. · PubMed · 1992 · 49 citations

Ocular Disease, Neurological Disorder, Pathology +16